BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9267059)

  • 1. Pneumococcal vaccine.
    Torzillo PJ
    Aust Fam Physician; 1997 Aug; 26(8):937-41. PubMed ID: 9267059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
    Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
    Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal vaccine.
    LaForce FM
    Semin Respir Infect; 1989 Dec; 4(4):293-8. PubMed ID: 2697052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: a 16-year study.
    Torzillo PJ; Morey F; Gratten M; Murphy D; Matters R; Dixon J
    Vaccine; 2007 Mar; 25(13):2375-8. PubMed ID: 17030079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the pneumococcal vaccine.
    Satterwhite TK
    Am Fam Physician; 1981 Nov; 24(5):209-12. PubMed ID: 7293914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumococcal vaccination].
    LĂ©ophonte P
    Rev Mal Respir; 1999 Nov; 16(5):763-6. PubMed ID: 10612144
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumococcal vaccine: a second look. Solution for SC or IM injection: pneumococcal vaccine.
    Prescrire Int; 1998 Feb; 7(33):16-8. PubMed ID: 10183394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvalent pneumococcal polysaccharide vaccines; a review of the literature.
    Requejo HI
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(3):130-8. PubMed ID: 8248704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking recommendations for use of pneumococcal vaccines in adults.
    Whitney CG; Schaffner W; Butler JC
    Clin Infect Dis; 2001 Sep; 33(5):662-75. PubMed ID: 11486289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults.
    Benin AL; O'Brien KL; Watt JP; Reid R; Zell ER; Katz S; Donaldson C; Parkinson A; Schuchat A; Santosham M; Whitney CG
    J Infect Dis; 2003 Jul; 188(1):81-9. PubMed ID: 12825175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
    Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis against postsplenectomy pneumococcal infection.
    Siddins M; Downie J; Wise K; O'Reilly M
    Aust N Z J Surg; 1990 Mar; 60(3):183-7. PubMed ID: 2183753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis against pneumococcal infection after splenectomy: a challenge for hospitals and primary care.
    Ejstrud P; Hansen JB; Andreasen DA
    Eur J Surg; 1997 Oct; 163(10):733-8. PubMed ID: 9373223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pneumococcal vaccination--yes or no?].
    Hess T
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1096-103. PubMed ID: 9691344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.
    Hausdorff WP; Bryant J; Paradiso PR; Siber GR
    Clin Infect Dis; 2000 Jan; 30(1):100-21. PubMed ID: 10619740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: pneumococcal polysaccharide vaccine usage--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 May; 33(20):273-6, 281. PubMed ID: 6425629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.